The stocks had a big run so once the slide started investors sold to lock in profits. I'm surprised it held up as well as it did considering the general market sell-off. Biotechs got hammered, I lost more on SGEN on a percentage basis then RPRX for no reason.
My newsletter mentioned that there might be some selling of RPRX on the release, but I blew it off as a bunch of dummies. Guess they were right, but the market played a big part in todays trading. They also said any selling would be a buying opportunity so I guess it nets out as a wash.
I think we trade sideways or even down until the FDA path for Androxal or pathology results are released. I see alot more questions on the board about safety, FDA, and delays so we may have lost some momentum. Hope I'm wrong.
News 
Market Data 
Discover 
AI
